Study guide

Survivorship, Rehabilitation, Recurrence, and Late Effects

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

Survivorship, Rehabilitation, Recurrence, and Late Effects

Key Takeaways Explain This Topic AI

Survivorship begins at diagnosis and includes surveillance, health promotion, late effects, psychosocial recovery, and primary-care coordination.

Rehabilitation should begin early to preserve function, manage symptoms, and support return to roles.

A survivorship care plan summarizes treatments, cumulative doses, expected late effects, and a surveillance schedule with named clinicians.

Anthracyclines and chest radiation cause delayed cardiomyopathy; doxorubicin lifetime dose is generally limited to about 450-550 mg/m2.

OCN scenarios test differentiating expected recovery from symptoms that require urgent evaluation.

Last updated: June 2026

  • Survivorship, Rehabilitation, Recurrence, and Late Effects
  • Survivorship as a phase of care

Survivorship begins at diagnosis and continues for life, but needs become most visible when active treatment ends. Patients may expect relief yet experience fatigue, fear, body-image change, financial strain, neuropathy, cognitive concerns ("chemo brain"), sexual changes, and uncertainty about follow-up. The nurse validates that recovery takes time and provides a plan explaining surveillance, health promotion, late effects, medications, and whom to call.

A frequently tested nuance is that the end of treatment is often emotionally harder than expected: the structure and frequent contact of active therapy disappear, follow-up visits trigger anxiety, and patients may feel pressure to "be grateful" while still struggling. Naming this experience and normalizing it is itself a therapeutic intervention, and dismissing distress because "the cancer is gone" is the wrong answer.

Survivorship care plans

A survivorship care plan (SCP) summarizes diagnosis, stage, relevant biomarkers, treatments and dates, cumulative agent doses, radiation fields, expected late effects, a surveillance schedule, health maintenance, and responsible clinicians. It supports - but does not replace - conversation. The nurse confirms the patient understands the difference among surveillance for recurrence, screening for new primary cancers, and routine primary care.

For example, a colon cancer survivor may need carcinoembryonic antigen (CEA) monitoring and surveillance colonoscopy for recurrence, age-appropriate mammography or lung screening for new primaries, and ongoing blood-pressure and vaccination management through primary care - three distinct tracks the patient must not confuse. Clarifying which clinician owns each track prevents both duplicated testing and dangerous gaps.

  • Survivorship issue Nursing focus
  • Fatigue Assess sleep, anemia, mood, activity, medications, and recurrence red flags
  • Neuropathy Fall safety, pain control, dose history, rehabilitation referral
  • Lymphedema risk Limb measurement, infection prevention, compression referral
  • Cognitive concerns Validate, screen contributors, teach compensatory strategies, refer if persistent
  • Fear of recurrence Assess severity, triggers, coping, and psychosocial support need
  • Rehabilitation and function

Cancer rehabilitation includes physical, occupational, speech-language, lymphedema, and pelvic-floor therapy, plus vocational and exercise-oncology support. It should not be reserved for severe disability. A head and neck patient may need swallowing exercises before, during, and after radiation. A breast surgery patient with shoulder restriction needs early range-of-motion work. A patient with bone metastases needs activity planning that protects skeletal stability. Assess activities of daily living, gait, falls, pain, weakness, swallowing, continence, cognition, and return-to-work capacity.

Functional decline is a clinical problem, not an inevitability.

Recurrence concerns and red flags

Fear of recurrence is common; patients scan their bodies and feel anxious before surveillance. Dismissing fear is not therapeutic. A helpful response: "Many survivors worry about this. Let's talk about which changes need a call and what support helps when worry takes over." Symptoms needing evaluation vary by history but may include persistent new focal pain, neurologic deficits, unexplained weight loss, new cough or dyspnea, jaundice, persistent headache, seizures, new lumps, bleeding, or bowel/bladder change.

New focal back pain in a prostate cancer survivor should not be attributed to aging without assessment, because bone metastasis and spinal cord compression are real risks; likewise, a new persistent headache or seizure in a breast or lung cancer survivor warrants evaluation for brain metastasis rather than reassurance. The skill the exam rewards is separating expected post-treatment recovery from red flags that demand prompt workup.

Late and delayed treatment effects

Late effects can emerge months to years after therapy. Critical agent-specific associations the exam tests:

Anthracyclines (doxorubicin) and chest radiation : cardiomyopathy and heart failure; doxorubicin lifetime dose is generally capped near 450-550 mg/m2, and HER2-directed therapy (trastuzumab) adds cardiac risk

  • Bleomycin : pulmonary fibrosis (dose-related); supplemental oxygen exposure can worsen it
  • Platinums, taxanes, vinca alkaloids, bortezomib : peripheral neuropathy

Cyclophosphamide / ifosfamide : hemorrhagic cystitis (mesa and hydration are protective); alkylators raise secondary leukemia risk

Alkylators and topoisomerase II inhibitors : secondary myelodysplasia or acute leukemia

Immune checkpoint inhibitors : delayed immune-related adverse events of skin, gut, liver, lung, endocrine organs, kidney, and nerves

Endocrine late effects include premature menopause, infertility, thyroid dysfunction, adrenal insufficiency, osteoporosis, metabolic changes, and sexual dysfunction. Survivors also need infection prevention, vaccination review (with attention to function after splenectomy or stem-cell transplant), and aggressive cardiovascular risk management, because several treatments amplify long-term cardiac and vascular risk.

Recognizing which specific agent maps to which delayed organ toxicity - anthracycline to heart, bleomycin to lung, cisplatin to nerves and kidneys, alkylator to secondary leukemia - is a high-yield exam pattern, because the correct surveillance and the correct response to a new symptom both depend on the treatment the patient actually received.

Coordination with primary care

Survivorship works best when oncology and primary care share responsibility. Oncology generally guides recurrence surveillance and treatment-specific late effects; primary care manages general prevention, chronic disease, vaccination, and noncancer screening. The nurse clarifies ownership so a patient never hears "that is not our department." A shared written plan, an explicit handoff note, and a named contact for new symptoms keep the patient from falling between the two services.

Survivorship is therefore active nursing work - surveillance scheduling, late-effect monitoring, recurrence education, psychosocial support, and warm handoffs - not a single discharge visit, and the OCN exam consistently frames it as ongoing care rather than the end of the relationship.